Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"DNA strand breakage via free radical generation" refers to the chemical cleavage of the phosphodiester backbone in cellular DNA caused by highly reactive molecules known as free radicals, particularly those derived from oxygen species such as hydroxyl (.OH) and peroxyl (ROO.) radicals. These species can be generated endogenously through normal cellular metabolism or exogenously by radiation, chemicals, or certain drugs. The resulting single-strand and double-strand breaks compromise genomic integrity—leading potentially to mutations, carcinogenesis, neurodegeneration, aging processes—and can trigger cell death if unrepaired. This phenomenon is central both in disease pathogenesis and as an intended effect for some anticancer therapies but does not represent a discrete molecular drug target.
For drugs targeting this process: - Generation of reactive oxygen species/free radicals that attack the sugar-phosphate backbone or bases in DNA leading to single-strand and double-strand breaks. - Scavenging/inhibition of free radicals to prevent oxidative damage and subsequent strand breakage.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA strand breakage via free radical generation.